CAS: 1935694-88-4
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Spartalizumab REF: TM-T77075CAS: 1935694-88-4 | SDS-PAGE:95.2%;SEC-HPLC:96.3% | 170,00 €~872,00 € | Vie 28 Mar 25 |
 | Spartalizumab REF: 3D-CLA1490CAS: 1935694-88-4 | - - - | A consultar | Lun 07 Abr 25 |
Spartalizumab
CAS:1935694-88-4
"Spartalizumab (PDR001), a humanized IgG4 monoclonal antibody, targets PD-1 to inhibit PD-L1/L2 interactions, useful in …
Pureza:
SDS-PAGE:95.2%;SEC-HPLC:96.3%
Forma y color:
Liquid
Peso molecular:
145.74 kDa
Ref: TM-T77075
| 1mg | 170,00 € | ||
| 5mg | 512,00 € | ||
| 10mg | 872,00 € |
Entrega estimada en Estados Unidos, el Viernes 28 de Marzo de 2025
Spartalizumab
CAS:1935694-88-4
Monoclonal antibody targeting PD-1 (CD279), being researched for melanoma
Ref: 3D-CLA1490
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Lunes 7 de Abril de 2025
